Growth Metrics

Protalix BioTherapeutics (PLX) Assets (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 24.28%
Dec 31, 2025 0.10%
Sep 30, 2025 4.81%
Jun 30, 2025 6.22%
Mar 31, 2025 0.65%
Dec 31, 2024 19.26%
Sep 30, 2024 -32.75%
Jun 30, 2024 1.91%
Mar 31, 2024 6.38%
Dec 31, 2023 -3.58%
Sep 30, 2023 -0.96%
Jun 30, 2023 32.84%
Mar 31, 2023 19.31%
Dec 31, 2022 -1.63%
Sep 30, 2022 -6.48%
Jun 30, 2022 -11.33%
Mar 31, 2022 -7.16%
Dec 31, 2021 -11.76%
Sep 30, 2021 -22.85%
Jun 30, 2021 5.27%
Mar 31, 2021 51.31%
Dec 31, 2020 -6.05%
Sep 30, 2020 0.84%
Jun 30, 2020 -13.47%
Mar 31, 2020 82.58%
Dec 31, 2019 -15.52%
Sep 30, 2019 -2.74%
Jun 30, 2019 -9.50%
Mar 31, 2019 -0.14%
Dec 31, 2018 -7.02%
Sep 30, 2018 27.12%
Jun 30, 2018 -20.18%
Mar 31, 2018 -10.27%
Dec 31, 2017 18.27%
Sep 30, 2017 3.49%
Jun 30, 2017 -17.89%
Mar 31, 2017 -12.64%
Dec 31, 2016 16.71%
Sep 30, 2016 -10.64%
Jun 30, 2016 -9.67%
Mar 31, 2016 -10.22%
Mar 31, 2014 -8.75%
Dec 31, 2013 -6.46%
Sep 30, 2013 94.45%
Jun 30, 2013 -10.92%
Mar 31, 2013 -11.16%
Dec 31, 2012 1.74%
Sep 30, 2012 -8.22%
Jun 30, 2012 23.14%
Mar 31, 2012 32.16%
Dec 31, 2011 -14.84%
Sep 30, 2011 -15.38%